Literature DB >> 3172356

The relationship of circulating antisperm antibodies to sperm surface antibodies in infertile men.

W J Hellstrom1, J W Overstreet, S J Samuels, E L Lewis.   

Abstract

The correlation between the amount and location of antisperm antibody binding to the sperm surface and the level measured in the serum has not been previously reported. Hence, the value and limitations of screening blood sera from men with suspected immunologic infertility are not currently known. In this study 70 paired sera and semen samples were assayed by the immunobead test (IBT). A screening protocol for blood sera was constructed to be 100% sensitive for detecting semen specimens with 20% or more of sperm binding IgG or IgA immunobeads. The specificity of this screening protocol was determined to be 79%. Serum IgA was not a good predictor of IgA on the sperm surface. The true positive predictive rate for antisperm antibodies on the sperm surface using circulating antisperm antibodies as a screening assay was estimated to be as low as 35%. There was little correlation between the site of immunobead binding following passive antibody transfer from patients' sera to donor sperm and the site of naturally occurring antibodies on the patients' sperm surface. Although direct assessment of antibodies on the sperm surface is preferred, these data suggest that serum IgG alone can be used as a sensitive screening assay for antisperm antibodies in men. A positive screen dictates that a direct assay on semen should be performed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172356     DOI: 10.1016/s0022-5347(17)41922-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

Review 1.  Laboratory testing in the evaluation of male infertility. A rational approach.

Authors:  M Sigman
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

2.  Electrovasogram in patients with obstructive azoospermia and absent vas deferens.

Authors:  A Shafik
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.